Ownership history in MATHER GROUP, LLC. · 6 quarters on record
This page tracks every 13F SEC filing in which MATHER GROUP, LLC. reported a position in TAKEDA PHARMACEUTICAL CO LTD (TAK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 104 | — | 0% | 0.00% | $2K | $14.64 |
| 2025 Q1 | REDUCED | 104 | -1 | -1.0% | 0.00% | $2K | $14.87 |
| 2024 Q4 | REDUCED | 105 | -8 | -7.1% | 0.00% | $1K | $12.94 |
| 2024 Q3 | ADDED | 113 | +109 | +2725.0% | 0.00% | $2K | $13.90 |
| 2024 Q2 | REDUCED | 4 | -29 | -87.9% | 0.00% | $56 | $12.36 |
| 2024 Q1 | INITIATED | 33 | — | — | 0.00% | $471 | — |
As of 2025 Q4 — sorted by position size